Entries by AMPadmin

Is Parkinson’s Disease a Bully?

We have all heard of them, and many of us, in one way or another, have encountered them. Some of us (hopefully, with regret) have been one. Who am I talking about?  Bullies They intimidate us and physically hurt us. They embarrass us, taunting us with their words. We fear that they’ll defeat us. What […]

MRI Technique Helps Distinguish Between Parkinson’s and Progressive Supranuclear Palsy, Study Reports

A specific magnetic resonance imaging (MRI) measure can accurately predict the development of eye movement abnormalities, helping to identify patients who develop progressive supranuclear palsy with parkinsonism (PSP-P) after an initial diagnosis of Parkinson’s, a study shows. The study, “Refining initial diagnosis of Parkinson’s disease after follow‐up: A 4‐year prospective clinical and magnetic resonance imaging study,” appeared in […]

Iowa City is Next Stop for Parkinson’s Foundation’s Team Training Program

The Parkinson’s Foundation is bringing Allied Team Training for Parkinson’s (ATTP), its signature professional education program, to Iowa City, Iowa, on March 27-30. The program is intended to help medical professionals from diverse disciplines learn the best techniques in Parkinson’s care.  Using a dynamic team-based approach, the training program is geared toward physicians, physician assistants; […]

The Compassionate Warrior in the Battle Against Parkinson’s

“C” is for compassion in my CHRONDI Creed, a warrior’s guide in the battle against Parkinson’s disease. It may seem odd to label a warrior as compassionate. Normally we picture the warrior as fierce, brave, courageous, and strong. We don’t often associate compassion with such an image. However, in the battle against chronic disease, being both […]

Behavioral, Metabolic Changes Linked to Sleep Restriction Could Foretell Parkinson’s, Animal Study Suggests

Chronic sleep restriction alters movement, worsens cognitive dysfunction and induces changes in the levels of several amino acids — the building blocks of proteins — and other markers in rats with Parkinson’s, according to a new study. According to researchers, these findings could enable the use of biomarkers to identify those at risk of developing […]

ProMIS Neurosciences Develops Antibodies Targeting Toxic Forms of Alpha-Synuclein

ProMIS Neurosciences has identified several antibody candidates that specifically target the toxic forms of alpha-synuclein, a key component of Lewy bodies that underlie the development of Parkinson’s disease. In vitro (in the lab) studies have shown that ProMIS’s antibody candidates for Parkinson’s disease have a high specificity for toxic forms of alpha-synuclein without binding to non-toxic essential forms of the […]

L‐DOPA Treatment Prevents Age-related Iron Accumulation, Mouse Study Finds

Levodopa (L-DOPA) therapy is neuroprotective and prevents age-related iron accumulation in the substantia nigra, a brain region involved in Parkinson’s disease. The study with that finding, “L-DOPA modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson’s disease,” was published in the Journal of Neurochemistry. L-DOPA is sill the primary […]

Have You Joined Our Parkinson’s News Today Forums Yet?

The Parkinson’s News Today Forums were created to allow those of us with this disease to lean on and learn from each other, and most importantly, laugh together. The forums also aim to help caregivers, family members, and friends to understand the daily challenges of those living with Parkinson’s disease (PD). Have you ever tried […]